To whom is the new Tramadol label adressed?
July 27th, 2010In our reactions to news no doubt we all have our own experiences, but we do rely on other people’s opinions too. Thus, if we believe the benefits of a “product” outweigh the costs, we will probably buy it or take part in the activity. Althogh if we think we might lose out, we’ll try to avoid or reject the “product”. But avoiding something, you are not able to find out the truth about the “product”. Most marketing campaigns rely on optimistic statements, which is natural, and the result may leave you disappointed. But your experience gives you the chance to check your expectations. It’ s worse, when we accept advice from people who think the same way we do, rather than from thу people who might don’t share our beliefs. A trust issue, isn’t it?
Let’s look at how we react when an “expert” tells us something. It usually depends on if we think the experts seem good or bad to us, e.g. in the pay of the manufacturers or committed to a particular political view. If that’s the case, the fact the advice might be accurate and timely will make no difference. It will be ignored.
Risk is similar to uncertainty, something you can’t measure easily. So the problem of how we react depends on how quickly the risk might come true. Try telling a cigarette smoker there’s a risk of cancer in twenty years time. It’s all about the pleasure now and the delusion you will do something about it before the risk gets more real.
Recently the FDA has announced a change in the labeling for Tramadol. They have also sent out a message to all doctors, telling them to change to the way in which they write prescriptions. The reason seems to be the death of one or two people as a result of taking opioid painkillers.
This is not so clear because the FDA don’t announce how many have died but, given past experience, we can assume the number is very small. The company tends to work on a precautionary basis and, if tens were dying, they would take the drug off the market. So waht’ sthe cause of these people’s death? It comes down to overdoses – a tiny percentage of cases. It seems one or two people who were emotionally disturbed and depressed died when they took too much of the drug. All health specialists are advised to discuss the use of painkillers such as Tramadol namely concerning its interactions with antidepressant drugs or tranquillizers.
Assuming the FDA is musch in the pocket of the last Administration than under Big Pharma. This fact would make this advice more credible. Anyway the reality of the the label’s warning only seems to be a red light to a tiny number of people given the millions who are on course of Tramadol. While we would never suggest you ignore an FDA announcement, you have to answer a simple question. When the benefits of this painkiller are real to you, and the risk only applies to people who are severely mentally ill, are you going to change your response? Just don’t be scared to much about the new label’s notice if pain is your only problem.
No Comments »